AMTM vs TECH · rev $14.39B vs P/E 65, rev $1.22B
Amentum Holdings Inc. (AMTM) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Amentum Holdings Inc. (AMTM) is a specialty business services company listed on US.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported AMTM revenue for 2025-10-03 was $14.39B. Net income was $59.0M. Revenue was up 71.6% from 2024-09-27 to 2025-10-03. AMTM currently screens at market cap $4.87B.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
AMTM currently screens at market cap $4.87B. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the AMTM and TECH stock pages for the full models.
Not investment advice.